Literature DB >> 14512157

An immuno-affinity method for the purification of mannose 6-phosphate receptor proteins.

Koduru Suresh1, Siva Kumar Nadimpalli.   

Abstract

In a recent study, we have developed an ELISA method to quantify the mannose 6-phosphate receptor (MPR) proteins [J. Biochem. Biophys. Methods 52 (2002) 111]. In the present study, we have used the goat MPR 300 antibody and peptide specific antibodies to human MPR 46 to develop simple and efficient immuno-affinity matrices, which can be used to purify the MPR proteins from goat liver in a single step. The identity of the immuno-affinity purified receptors is confirmed by their molecular masses as well as by their immunoreactivity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512157     DOI: 10.1016/s0165-022x(03)00148-9

Source DB:  PubMed          Journal:  J Biochem Biophys Methods        ISSN: 0165-022X


  4 in total

1.  Molecular cloning of goat Mannose 6-phosphate receptors, MPR 300 and 46.

Authors:  Koduru Suresh; Suryanarayana Raju Vegiraju; Siva Kumar Nadimpalli
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

2.  Role of cation independent mannose 6-phosphate receptor protein in sorting and intracellular trafficking of lysosomal enzymes in chicken embryonic fibroblast (CEF) cells.

Authors:  Sivaramakrishna Yadavalli; Siva Kumar Nadimpalli
Journal:  Glycoconj J       Date:  2009-11-05       Impact factor: 2.916

3.  Mannose-6-phosphate receptors (MPR 300 and 46) from the highly evolved invertebrate Asterias rubens (Echinodermate): biochemical and functional characterization of MPR 46 protein.

Authors:  Sivaramakrishna Yadavalli; Siva Kumar Nadimpalli
Journal:  Glycoconj J       Date:  2008-07-06       Impact factor: 2.916

4.  Lysosomal enzymes and mannose 6-phosphate receptors in the lacrimal drainage system: Evidence and its potential implications.

Authors:  Mohammad Javed Ali; Ashapogu Venugopal; Kavyashree Sakharayapatna Ranganath; Nadimpalli Siva Kumar
Journal:  Indian J Ophthalmol       Date:  2018-11       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.